Status:
WITHDRAWN
Impact of Systematic Imaging for Follow up of Patients With Ovarian, Fallopian Tube or Primary Peritoneum Cancer
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Advanced Stage Serous Epithelial Cancer of the Ovary
Advanced Stage Cancer of Tubes
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
After well-conducted treatment of ovarian, tubal and primary peritoneum cancer by maximum tumor reduction surgery and chemotherapy including platinum salt and paclitaxel, the clinical remission rate i...
Detailed Description
This is a randomized multi-center study. Randomization will be stratified on two major prognostic factors: * The BRCA mutation (germline or somatic) * the serous high or low grade histological subtyp...
Eligibility Criteria
Inclusion
- Patients aged at least 18 years.
- Patients in remission from proven stage III and above serous epithelial cancer of the ovary, peritoneum or tubes with complete macroscopic surgical resection (whether initial or interval)
- Signature of informed consent by the patient
- Affiliation to a French social security scheme (excluding AME)
Exclusion
- Patients with a contraindication to MRI or CT examination (wearing a material with magnetic properties : pacemaker, ferromagnetic material, etc.)
- Intolerance to iodinated contrast or gadolinium or severe renal failure (DFG \<30 ml/min/1.73 m2)
- Patients deprived of their liberty and patients Under legal protection (under guardianship or under curatorship)
- Patients participating in another interventional research (in particular research with radiological exposure as well
Key Trial Info
Start Date :
June 22 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 22 2021
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04826029
Start Date
June 22 2021
End Date
June 22 2021
Last Update
December 10 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Pitié Salpêtrière
Paris, France, 75013